1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Natulab Laboratorio SA

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2000

Location

Sao Paulo SP Brazil

Primary Industry

Pharmaceuticals

About

Founded in 2000 and based in Sao Paulo, Brazil, Natulab Laboratorio SA is a manufacturer of medicinal and botanical OTC (over the counter) products. In April 2024, Patria Investments exited its stake in Natulab Laboratorio SA. The firm as of August 2024, has an operational facility in Santo Antônio de Jesus, Bahia. Natulab offers OTC medicines, herbal products, and vitamin supplements, to meet various health needs, from pain and fever relief to digestive health and respiratory support. The company’s portfolio, as of August 2024, exceeds 150 products, including well-known brands such as Seakalm, Maxalgina, and Viter C.
Current Investors
Patria Investimentos

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Health Foods & Nutritional Supplements, Pharmaceutical Research & Development
Website
www.natulab.com.br
Verticals
Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only

Deals

Deals Type
Secondary Buyout
Growth
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Natulab Laboratorio SA 03 Apr 2024
Completed Natulab Laboratorio SA 30 Sep 2013
Displaying 1-2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.